Intrexon Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
HALO | B | Halozyme Therapeutics, Inc. | 1.38 | |
PGEN | C | Precigen, Inc. | -1.34 |
Related Industries: Biotechnology
Related Stock Lists:
Biotechnology
Life Sciences
Antibodies
Aquaculture
Biological Engineering
Biology
Biopharmaceutical
Cattle
Clinical Trial Product
Cloning
Control Solutions
Diabetes
Diabetes Mellitus
Emerging Technologies
Enzymes
Gene Expression
Genetic Engineering
Halozyme
Hoffmann La Roche
Hyaluronidase
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
FBT | B | First Trust Amex Biotech Index Fund | 4.22 | |
FFLS | A | The Future Fund Long/Short ETF | 4.17 | |
FFND | A | The Future Fund Active ETF | 3.78 | |
PBE | B | PowerShares Dynamic Biotech & Genome | 3.17 | |
SCAP | A | InfraCap Small Cap Income ETF | 2.42 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Biotechnology
Life Sciences
Antibodies
Aquaculture
Biological Engineering
Biology
Biopharmaceutical
Cattle
Clinical Trial Product
Cloning
Control Solutions
Diabetes
Diabetes Mellitus
Emerging Technologies
Enzymes
Gene Expression
Genetic Engineering
Halozyme
Hoffmann La Roche
Hyaluronidase
- Intrexon
Precigen, Inc (formerly Intrexon Corporation, NASDAQ: PGEN) is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles